ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
4,967.23
-0.88%
US Tech 100
16,556.80
-2.24%
Dow Jones
37,986.40
0.56%
Brent Oil
86.625
0.00%
Bitcoin
63,772.16
-0.08%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Gsk Plc (GSK) Quote

Gsk Plc

Gsk Plc (GSK)

Goldseek Resources Inc
GSK plc
1,599.00
15.50
(0.98%)
Closed April 19 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
1,599.00
Bid
1,599.50
Ask
1,600.50
Volume
5,149,016
1,575.00 Day's Range 1,600.00
1,302.60 52 Week Range 1,719.80
Market Cap
65.873B
Previous Close
1,583.50
Open
1,579.50
Last Trade
51077
@
1587.149
(O)
Last Trade Time
Financial Volume
82,028,361p
VWAP
1,593.0881
Average Volume (3m)
8,589,314
Shares Outstanding
4,117,033,438
Dividend Yield
3.63%
PE Ratio
13.37
Earnings Per Share (EPS)
1.2
Revenue
30.33B
Net Profit
4.93B

About Gsk Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.gsk.com
Headquarters
Middlesex, Gbr
Founded
1970
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,583.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares outstanding. The market capitalization of Gsk is £65.87 billion. Gsk has a price to earnings ratio (PE ratio) of 13.37.

GSK Latest News

More News

GSK PLC Director/PDMR Shareholding

GSK PLC 19 April 2024   GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief...

11 hours ago
RNS Regulatory News

GSK PLC Director/PDMR Shareholding

GSK PLC 17 April 2024   GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief Executive...

April 17 2024
RNS Regulatory News

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a for ...

April 17 2024
Alliance News

GSK PLC GSK announces additional EAGLE-1 results

GSK PLC 17 April 2024   Issued: 17 April 2024, London UK   EAGLE-1 phase III data show potential for gepotidacin as a new oral treatment option for uncomplicated urogenital gonorrhoea (GC...

April 17 2024
RNS Regulatory News

GSK PLC Results from long-term data relating to Shingrix

GSK PLC 17 April 2024   Issued: 17 April 2024, London UK   New long-term data show Shingrix continues to provide high protection against shingles in adults aged 50 and over for more than a...

April 17 2024
RNS Regulatory News

GSK PLC Amendment - Director/PDMR Shareholding

GSK PLC 16 April 2024   The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 15 April 2024 at 15:30 under RNS No 6703K: -     A typographical...

April 16 2024
RNS Regulatory News

GSK's latest meningitis vaccine accepted for review by US regulator

GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths ...

April 16 2024
Alliance News

GSK PLC FDA accepts GSK meningitis vaccine candidate file

GSK PLC 16 April 2024   Issued: 16 April 2024, London UK   GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for regulatory review by US FDA   ·      Vaccine candidate provides broad...

April 16 2024
RNS Regulatory News

GSK PLC Director/PDMR Shareholding

GSK PLC 15 April 2024   GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief Executive...

April 15 2024
RNS Regulatory News

IN THE KNOW: Barclays ups GSK price target but HIV drug nerves remain

Barclays on Monday increased its share price target for GSK after adding in forecasts for five key pipeline assets. ...

April 08 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-32.5-1.992031872511631.51651.5157566459901612.83136484DE
4-79.4-4.730695900861678.41713157572279071648.17736501DE
12684.4415414761615311719.81514.885893141648.85227921DE
26112.47.560877169381486.61719.8137679439551557.79209598DE
52119.48.06974858071479.61719.81302.675325751491.95724214DE
156257.619.20381690771341.41824.41283.286336911509.39558086DE
260754.92125984252152418571190.889227391523.79641994DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

Discussion

View Full Feed
Rhodan Rhodan 48 seconds ago
Hey Crash, could you have a more negative position on ths?
TGLO
Deportes Deportes 1 minute ago
We Won fkgn pos
ENZC
mark5150 mark5150 2 minutes ago
You too and thanks for everything.
CLNV
Zardiw Zardiw 2 minutes ago
israel has been doing hideous things to Palestinians for 70 years......what triggered the jail break on Oct 7 was israel was about to normalize relations with Saudi Arabia.......and Hamas knew that would be the end of them.......so they had no choice.......besides, they were hoping israel's response
janice shell janice shell 2 minutes ago
I think not anymore. But I'm not sure.
frrol frrol 3 minutes ago
Reverse that. And I'm sure you can read well.
AVXL
I-Glow I-Glow 4 minutes ago
There are two patent applications and neither have been granted.

The first is a patent application and it hasn't been granted. Application Number: US17/820,629

Drug patents as I have shown are meaningless without passing FDA approved clinical trials.

They
ENZC
RIOgrande44 RIOgrande44 4 minutes ago
All I hear is you don't want to pay or you can't. I am not not sure, what your saying. Can you clarify.
Natural Trader Natural Trader 5 minutes ago
IRAN AND ISREAL killing gaza people think hard
Thompson Thompson 5 minutes ago
Why is it that most all KTRL projects never really appear to go well? Hum?
KRTL
frrol frrol 5 minutes ago
Don't take it personally.
AVXL
porty porty 5 minutes ago
Wow, lots of commentary today. I’ll wait for the NorthPeak assessment.
TGLO
OMOLIVES OMOLIVES 6 minutes ago
OH....by the way .... I love this song ...

https://www.youtube.com/watch?v=cfU2hCnaD-w

....and I am trying to find this slice of the venue @ Summerfest in Milwaukee, Wisconsin @ circa 2018 ...great riff but I need to hear it entirely ..lol


https:/
flatlander_60048 flatlander_60048 6 minutes ago
I agree with the other comment. CERCLA liability from Landfills, Superfund sites, etc could be as much if not more than the PWS settlement. This liability will take many years to play out and is only worsened by the fact that the new EPA drinking water limits for PFAS are ultra low. This means th
real777mellon real777mellon 6 minutes ago
I am having trouble finding the Classes of each LBHI creditor and the % they have been paid thru LBHI PT 28th distribution It took place 4 April 2024. Do you have anything besides the 28 March 2024 notice I could see the updated classes and their distributions/claims %?
LEHNQ
skydog526 skydog526 6 minutes ago
Let's be clear now. I nailed it again and said halving would be a slow float nothing burger.
BTCUSD
Westcoastplaya Westcoastplaya 6 minutes ago
Too funny. You really are a child
DBMM
Hercules1 Hercules1 7 minutes ago
https://twitter.com/randylus/status/1781413202338664949
WDRP
MarkTrouble MarkTrouble 8 minutes ago
https://www.cnn.com/2024/04/19/markets/trump-media-nasdaq-suspected-market-manipulation/index.html
CRGP
hedge_fun hedge_fun 8 minutes ago
What was the pps 3 weeks ago? How……

bout at the peak of the Torres Rally?

The dilution continues, bro!
SFRX
arizona1 arizona1 8 minutes ago
Do all the children of former presidents still get SS protection? Michael and Ron Reagan?
crescentmotor crescentmotor 10 minutes ago
Anavex YouTube: Noble Capital Markets Healthcare Conference

If I understood Dr. Missling correctly, in today's conference he opened the door with respect to presenting more data from the 2b/III trial in a presentation that could precede the full data release in the peer reviewed artic
AVXL
canthelpit canthelpit 10 minutes ago
GTCH THE GOVERNMENT sales eligability i beleive they are already registered since last year,,,pretty sure thats what i read. I just went page for page top to bottom alot of my d&d was listed in there going back years. This 10k is a good refrence point when looking for names, only the second time
GTCH
janice shell janice shell 10 minutes ago
lol, that's good!
Researchfyi Researchfyi 10 minutes ago
That’s a lot of prototypes too that can generate both revenues and operating costs.

Maybe Demo the Martin guitar and send their 20 sales reps to the companies with the highest product sales first.
LQMT

Your Recent History

LSE
GSK
Gsk
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved